Skip to Main Content

Paper Details

Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.
Transplant Cell Ther
2
2022

Datasets

Release 1.2